Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_assertion type Assertion NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_head.
- NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_assertion description "[The missense point mutation BRAF(V600E) was identified in 42% (13/31 cases) of papillary carcinomas and 33% (5/15 cases) of undifferentiated carcinomas but not in normal thyroid tissues, nodular hyperplasia, follicular adenomas, or follicular carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_provenance.
- NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_assertion evidence source_evidence_literature NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_provenance.
- NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_assertion SIO_000772 17714762 NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_provenance.
- NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_assertion wasDerivedFrom befree-2016 NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_provenance.
- NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_assertion wasGeneratedBy ECO_0000203 NP626328.RANIGojrvDvqZ7y-8m2dRq37agz5MKJMYzXKYqOpnQN6M130_provenance.